# OnCo record electra-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/electra-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "electra-therapeutics" ;
  schema:name "Electra Therapeutics"@en ;
  schema:alternateName "Electra Therapeutics, Inc."@en, "Electra Therapeutics Inc."@en ;
  schema:description "A US company making antibodies against SIRP proteins to remove overactive immune cells. Its lead drug is mainly for a dangerous inflammatory condition called sHLH, and it is also in an early trial for T-cell and NK-cell blood cancers that have come back."@en ;
  schema:url <https://onco.cc/companies/electra-therapeutics/>, <https://electra-therapeutics.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/2088082/000119312526389755/d61940ds1a.htm>, <https://electra-therapeutics.com/>, <https://electra-therapeutics.com/pipeline/>, <https://electra-therapeutics.com/ipsoprubart/>, <https://www.sec.gov/Archives/edgar/data/2088082/000119312526396646/d185250d8k.htm>, <https://www.sec.gov/Archives/edgar/data/2088082/000119312526395670/d61940d424b4.htm>, <https://clinicaltrials.gov/study/NCT07465835>, <https://www.racap.com/portfolio/electra-therapeutics>, <https://www.orbimed.com/portfolio/> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/sirpa/> ;
  onco:drugs <https://onco.cc/drugs/ipsoprubart/> .